ArticleJournal of oral biology and craniofacial research
Curcumin-infused carboxymethyl cellulose-gelatin gel for oral tissue repair: Preliminary evaluation.
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to develop and evaluate a multifunctional oral wound care gel (OWCG) formulated with carboxymethyl cellulose (CMC), gelatin (GEL), and curcumin (CUR) to enhance oral soft tissue regeneration. Methods: CMC was synthesized through etherification, whereas CUR was extracted using a modified ethanol-based method. OWCG was prepared and crosslinked using 5 % citric acid. Physicochemical characterization including Fourier-transform infrared (FTIR) spectroscopy, high-resolution scanning electron microscopy (HR-SEM), thermogravimetric analysis (TGA), swelling behavior, and in vitro drug release were assessed. Biological evaluations included in vitro anti-inflammatory, antibacterial, and MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assays on fibroblast (3T3-L1) cell, and scratch wound healing assays. Results: OWCG exhibited a maximum swelling capacity of 86 % at neutral pH and 83 % CUR release under alkaline conditions within 24 h. In vitro protein denaturation inhibition was 82.4 %, confirming its anti-inflammatory efficacy. The gel exhibited notable antibacterial activity. MTT assays demonstrated over 90 % cell viability at 48 h, and scratch wound assays showed 90 % wound closure within the same timeframe. Conclusion: OWCG demonstrated good biocompatibility, antimicrobial efficacy, and wound healing potential, supporting its use in oral wound care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.